
Your Feed
Update on BMS-986393, a GPRC5D #Myeloma CAR-T | Susan Bal, MD | #ASH24
Update on BMS-986393, a GPRC5D #Myeloma CAR-T | Susan Bal, MD | #ASH24
Addressing Socioeconomic Challenges in Acute Myeloid Leukemia Treatment | Mohamed Sorror, MD | #ASH24
Addressing Socioeconomic Challenges in Acute Myeloid Leukemia Treatment | Mohamed Sorror, MD | #ASH24
Daratumumab vs Lenalidomide As Myeloma Maintenance Therapy | Sridevi Rajeeve, MD | #ASH24
Daratumumab vs Lenalidomide As Myeloma Maintenance Therapy | Sridevi Rajeeve, MD | #ASH24
What is MGUS?
Iberdomide Combos Post-ASCT in Myeloma: Eliminating Residual Disease (COMMANDER)
Mezigdomide in New Combos: Early Results for Relapsed/Refractory Myeloma
MRD Progress in Newly Diagnosed #Myeloma, Quad Induction Therapy and ASCT |Luciano Costa, MD| #ASH24
MRD Progress in Newly Diagnosed #Myeloma, Quad Induction Therapy and ASCT |Luciano Costa, MD| #ASH24




